Geneos Wealth Management’s Eaton Vance Enhance Equity Income Fund II EOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $36K | Hold |
1,761
| – | – | ﹤0.01% | 1551 |
|
|
2025
Q4 | $41.2K | Hold |
1,761
| – | – | ﹤0.01% | 1467 |
|
|
2025
Q3 | $42.1K | Hold |
1,761
| – | – | ﹤0.01% | 1448 |
|
|
2025
Q2 | $42.6K | Sell |
1,761
-1,221
| -41% | -$26.9K | ﹤0.01% | 1658 |
|
|
2025
Q1 | $62.9K | Buy |
2,982
+1,761
| +144% | +$41.1K | ﹤0.01% | 1795 |
|
|
2024
Q4 | $29.2K | Hold |
1,221
| – | – | ﹤0.01% | 1551 |
|
|
2024
Q3 | $26.5K | Hold |
1,221
| – | – | ﹤0.01% | 1446 |
|
|
2024
Q2 | $26.6K | Hold |
1,221
| – | – | ﹤0.01% | 1260 |
|
|
2024
Q1 | $24.6K | Hold |
1,221
| – | – | ﹤0.01% | 1292 |
|
|
2023
Q4 | $22.9K | Hold |
1,221
| – | – | ﹤0.01% | 1304 |
|
|
2023
Q3 | $21K | Hold |
1,221
| – | – | ﹤0.01% | 1355 |
|
|
2023
Q2 | $21.8K | Hold |
1,221
| – | – | ﹤0.01% | 1341 |
|
|
2023
Q1 | $20K | Hold |
1,221
| – | – | ﹤0.01% | 1346 |
|
|
2022
Q4 | $20.2K | Sell |
1,221
-370
| -23% | -$6.18K | ﹤0.01% | 1336 |
|
|
2022
Q3 | $24K | Sell |
1,591
-480
| -23% | -$8.51K | ﹤0.01% | 1261 |
|
|
2022
Q2 | $34K | Hold |
2,071
| – | – | ﹤0.01% | 1448 |
|
|
2022
Q1 | $43K | Hold |
2,071
| – | – | ﹤0.01% | 1449 |
|
|
2021
Q4 | $50K | Hold |
2,071
| – | – | ﹤0.01% | 1481 |
|
|
2021
Q3 | $48K | Buy |
2,071
+701
| +51% | +$16.8K | ﹤0.01% | 1510 |
|
|
2021
Q2 | $32K | Hold |
1,370
| – | – | ﹤0.01% | 1679 |
|
|
2021
Q1 | $31K | Hold |
1,370
| – | – | ﹤0.01% | 1856 |
|
|
2020
Q4 | $28K | Hold |
1,370
| – | – | ﹤0.01% | 1728 |
|
|
2020
Q3 | $24K | Hold |
1,370
| – | – | ﹤0.01% | 1570 |
|
|
2020
Q2 | $23K | Hold |
1,370
| – | – | ﹤0.01% | 1557 |
|
|
2020
Q1 | $19K | Hold |
1,370
| – | – | ﹤0.01% | 1530 |
|
|
2019
Q4 | $24K | Hold |
1,370
| – | – | ﹤0.01% | 1603 |
|
|
2019
Q3 | $23K | Hold |
1,370
| – | – | ﹤0.01% | 1536 |
|
|
2019
Q2 | $23K | Hold |
1,370
| – | – | ﹤0.01% | 1560 |
|
|
2019
Q1 | $22K | Hold |
1,370
| – | – | ﹤0.01% | 1524 |
|
|
2018
Q4 | $19K | Sell |
1,370
-396
| -22% | -$6.21K | ﹤0.01% | 1514 |
|
|
2018
Q3 | $31K | Hold |
1,766
| – | – | ﹤0.01% | 1388 |
|
|
2018
Q2 | $29K | Hold |
1,766
| – | – | ﹤0.01% | 1295 |
|
|
2018
Q1 | $27K | Hold |
1,766
| – | – | ﹤0.01% | 1255 |
|
|
2017
Q4 | $26K | Hold |
1,766
| – | – | ﹤0.01% | 1282 |
|
|
2017
Q3 | $26K | Hold |
1,766
| – | – | ﹤0.01% | 1219 |
|
|
2017
Q2 | $25K | Sell |
1,766
-800
| -31% | -$11.4K | ﹤0.01% | 1185 |
|
|
2017
Q1 | $34K | Buy |
2,566
+800
| +45% | +$10.7K | ﹤0.01% | 1030 |
|
|
2016
Q4 | $22K | Hold |
1,766
| – | – | ﹤0.01% | 1139 |
|
|
2016
Q3 | $24K | Hold |
1,766
| – | – | ﹤0.01% | 1062 |
|
|
2016
Q2 | $22K | Hold |
1,766
| – | – | ﹤0.01% | 1082 |
|
|
2016
Q1 | $22K | Buy |
+1,766
| New | +$21.8K | ﹤0.01% | 1058 |
|
Other funds holding EOS
GC
Geneos Wealth Management's EOS Position: Q1 2026 in Review
Geneos Wealth Management held its Eaton Vance Enhance Equity Income Fund II (EOS) position steady in Q1 2026 at 1,761 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #1551.
Geneos Wealth Management first reported a position in EOS in Q1 2016 and has held it in 41 quarters since. The position peaked at $62.9K in Q1 2025. 124 funds tracked by Wall St. Rank hold EOS as of Q1 2026.
- Geneos Wealth Management held 1,761 shares of Eaton Vance Enhance Equity Income Fund II worth $36K as of Q1 2026.
- Geneos Wealth Management left its Eaton Vance Enhance Equity Income Fund II share count unchanged in Q1 2026.
- Eaton Vance Enhance Equity Income Fund II made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1551 holding.
- Geneos Wealth Management first reported a position in Eaton Vance Enhance Equity Income Fund II in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's Eaton Vance Enhance Equity Income Fund II position peaked at $62.9K in Q1 2025.
- 124 funds tracked by Wall St. Rank held Eaton Vance Enhance Equity Income Fund II as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.